AbbVie (ABBV) declines 1.30% to $244.78 in Tuesday afternoon trading, on track for its seventh straight session of losses.
Over the past six trading sessions, the stock has declined 5.1%, compared with a 0.44% gain for the broader S&P 500 index. Year to date, AbbVie